Nevro Corp (NVRO) PT Raised to $92 at Piper Sandler on Physician Survey Results
Tweet Send to a Friend
Piper Sandler analyst Adam Maeder raised the price target on Nevro Corp (NYSE: NVRO) to $92.00 (from $90.00) after data ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
